Lang bekannt, in neuem Licht: Alport-Syndrom und Alport-Spektrum-Erkrankung
- 24 July 2026
- journal article
- leitthema
- Published by Springer Nature in Die Nephrologie
- Vol. 21 (5) , 302-311
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Systematic Review of IgA Nephropathy Coexisting With Alport SyndromeKidney International Reports, 2026
- SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and AlbuminuriaJAMA, 2026
- Alport Syndrome is a Partial Tubulointerstitial Disease of the KidneyKidney International Reports, 2025
- COL4A5-p.Gly624Asp is the Predominant Variant in Europe Associated With a Mild Alport Syndrome PhenotypeKidney International Reports, 2025
- SGLT2-Inhibition in Patients With Alport SyndromeKidney International Reports, 2024
- Finerenone and other future therapeutic options for Alport syndromeJournal of Rare Diseases, 2023
- Heterozygous Pathogenic COL4A3 and COL4A4 Variants (Autosomal Dominant Alport Syndrome) Are Common, and Not Typically Associated With End-Stage Kidney Failure, Hearing Loss, or Ocular AbnormalitiesKidney International Reports, 2022
- Comparison between conventional and comprehensive sequencing approaches for genetic diagnosis of Alport syndromeMolecular Genetics & Genomic Medicine, 2019
- Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant?Kidney International Reports, 2018
- A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseasesKidney International, 2018